Published in Am J Obstet Gynecol on September 30, 2015
Type 2 diabetes mellitus induces congenital heart defects in murine embryos by increasing oxidative stress, endoplasmic reticulum stress, and apoptosis. Am J Obstet Gynecol (2016) 0.80
The green tea polyphenol EGCG alleviates maternal diabetes-induced neural tube defects by inhibiting DNA hypermethylation. Am J Obstet Gynecol (2016) 0.78
High glucose-induced oxidative stress represses sirtuin deacetylase expression and increases histone acetylation leading to neural tube defects. J Neurochem (2016) 0.77
Superoxide dismutase 2 overexpression alleviates maternal diabetes-induced neural tube defects, restores mitochondrial function and suppresses cellular stress in diabetic embryopathy. Free Radic Biol Med (2016) 0.76
microRNA expression profiling and functional annotation analysis of their targets modulated by oxidative stress during embryonic heart development in diabetic mice. Reprod Toxicol (2016) 0.75
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A (1995) 24.77
Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science (2001) 23.83
HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science (2001) 22.06
C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell (2001) 19.75
Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev (2001) 13.15
A conserved family of prolyl-4-hydroxylases that modify HIF. Science (2001) 11.50
HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J (1998) 10.08
Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A (1998) 9.56
Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J (1998) 9.36
Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev (1999) 9.02
Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception (2011) 8.80
Role of oxidative stress in development of complications in diabetes. Diabetes (1991) 8.27
Biochemistry of nitric oxide and its redox-activated forms. Science (1992) 7.72
Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem (2000) 7.25
Vasculogenesis. Annu Rev Cell Dev Biol (1995) 5.41
ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep (2001) 5.32
Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell (1994) 5.12
ENZYMATIC SYNTHESIS OF DEOXYRIBONUCLEOTIDES. IV. ISOLATION AND CHARACTERIZATION OF THIOREDOXIN, THE HYDROGEN DONOR FROM ESCHERICHIA COLI B. J Biol Chem (1964) 4.36
Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem (1999) 3.95
Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Blood (2000) 2.98
Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med (1981) 2.89
Update on overall prevalence of major birth defects--Atlanta, Georgia, 1978-2005. MMWR Morb Mortal Wkly Rep (2008) 2.83
Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol (2006) 2.80
Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer. J Cell Physiol (2002) 2.69
Redox signaling and the MAP kinase pathways. Biofactors (2003) 2.54
Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science (1998) 2.51
Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol (1997) 2.27
Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat Med (1999) 2.25
Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol (1997) 2.17
Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull (1993) 2.15
Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development. Dev Dyn (2001) 1.93
Multilineage embryonic hematopoiesis requires hypoxic ARNT activity. Genes Dev (1999) 1.92
On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leukoc Biol (1995) 1.77
Risk of minor and major fetal malformations in diabetics with high haemoglobin A1c values in early pregnancy. Br Med J (Clin Res Ed) (1984) 1.77
Type 2 diabetes in pregnancy: a growing concern. Lancet (2002) 1.73
Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc Natl Acad Sci U S A (1996) 1.68
Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ (2005) 1.62
Structure, function, and mechanism of thioredoxin proteins. Antioxid Redox Signal (2010) 1.61
Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome. Free Radic Biol Med (2007) 1.56
First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology (1989) 1.53
Initiation of hematopoiesis and vasculogenesis in murine yolk sac explants. Blood (1995) 1.48
Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol Lett (1994) 1.47
Preventable health and cost burden of adverse birth outcomes associated with pregestational diabetes in the United States. Am J Obstet Gynecol (2014) 1.46
Activation of oxidative stress signaling that is implicated in apoptosis with a mouse model of diabetic embryopathy. Am J Obstet Gynecol (2008) 1.46
Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes. Am J Obstet Gynecol (2015) 1.43
Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. Biochem Pharmacol (1995) 1.42
Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J Immunol (1991) 1.40
Embryonic origins of mammalian hematopoiesis. Exp Hematol (2003) 1.36
Nitric oxide in parasitic infections. Int Immunopharmacol (2001) 1.35
Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes (1999) 1.30
Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes (1999) 1.28
Mitogen-activated protein kinase signaling. Int Rev Neurobiol (2004) 1.27
Arachidonic acid prevents hyperglycemia-associated yolk sac damage and embryopathy. Am J Obstet Gynecol (1986) 1.26
HIF-dependent hematopoietic factors regulate the development of the embryonic vasculature. Dev Cell (2006) 1.23
Involvement of c-Jun N-terminal kinases activation in diabetic embryopathy. Biochem Biophys Res Commun (2007) 1.22
NICE guidance on diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. NICE clinical guideline 63. London, March 2008. Diabet Med (2008) 1.21
Congenital malformations in offspring of diabetic mothers--animal and human studies. Rev Endocr Metab Disord (2003) 1.20
Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1. Biochem Biophys Res Commun (2002) 1.18
Apoptosis signal-regulating kinase 1 mediates cellular senescence induced by high glucose in endothelial cells. Diabetes (2006) 1.16
Expression of glutaredoxin in human coronary arteries: its potential role in antioxidant protection against atherosclerosis. Arterioscler Thromb Vasc Biol (2001) 1.15
Thioredoxin redox signaling in the ischemic heart: an insight with transgenic mice overexpressing Trx1. J Mol Cell Cardiol (2003) 1.13
Origin and differentiation of the yolk sac and extraembryonic mesoderm in presomite human and rhesus monkey embryos. Am J Anat (1978) 1.12
Nitric oxide (NO), a signaling molecule with a killer soul. Cell Death Differ (1999) 1.11
c-Jun NH2-terminal kinase 1/2 and endoplasmic reticulum stress as interdependent and reciprocal causation in diabetic embryopathy. Diabetes (2012) 1.09
Blockade of c-Jun N-terminal kinase activation abrogates hyperglycemia-induced yolk sac vasculopathy in vitro. Am J Obstet Gynecol (2008) 1.09
Hyperglycemia induces inducible nitric oxide synthase gene expression and consequent nitrosative stress via c-Jun N-terminal kinase activation. Am J Obstet Gynecol (2010) 1.09
Hyperglycemia-induced vasculopathy in the murine vitelline vasculature: correlation with PECAM-1/CD31 tyrosine phosphorylation state. Am J Pathol (1999) 1.09
Platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) tyrosine phosphorylation state changes during vasculogenesis in the murine conceptus. Am J Pathol (1997) 1.07
Multifactorial basis of the syndrome of diabetic embryopathy. Teratology (1996) 1.06
Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia. Am J Obstet Gynecol (2013) 1.05
Maternal hyperglycemia activates an ASK1-FoxO3a-caspase 8 pathway that leads to embryonic neural tube defects. Sci Signal (2013) 1.04
Mitochondrial NO and reactive nitrogen species production: does mtNOS exist? Nitric Oxide (2005) 1.04
Nitric oxide: a key regulator of myeloid inflammatory cell apoptosis. Cell Death Differ (2003) 1.03
Hyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activation. Am J Pathol (2001) 1.03
Targeted genes and interacting proteins of hypoxia inducible factor-1. Int J Biochem Mol Biol (2012) 1.02
Nitric oxide modulates murine yolk sac vasculogenesis and rescues glucose induced vasculopathy. Development (2004) 1.02
The impact of chronic hypertension and pregestational diabetes on pregnancy outcomes. Am J Obstet Gynecol (2012) 1.02
Apoptosis signal-regulating kinase 1 is involved not only in apoptosis but also in non-apoptotic cardiomyocyte death. Biochem Biophys Res Commun (2005) 1.01
SOD1 overexpression in vivo blocks hyperglycemia-induced specific PKC isoforms: substrate activation and consequent lipid peroxidation in diabetic embryopathy. Am J Obstet Gynecol (2011) 1.01
Ask1 gene deletion blocks maternal diabetes-induced endoplasmic reticulum stress in the developing embryo by disrupting the unfolded protein response signalosome. Diabetes (2014) 1.00
SOD1 suppresses maternal hyperglycemia-increased iNOS expression and consequent nitrosative stress in diabetic embryopathy. Am J Obstet Gynecol (2012) 1.00
Hyperglycemia and apoptosis: mechanisms for congenital malformations and pregnancy loss in diabetic women. Trends Endocrinol Metab (2001) 1.00
Superoxide dismutase 1 overexpression in mice abolishes maternal diabetes-induced endoplasmic reticulum stress in diabetic embryopathy. Am J Obstet Gynecol (2013) 0.99
The miR-322-TRAF3 circuit mediates the pro-apoptotic effect of high glucose on neural stem cells. Toxicol Sci (2014) 0.98
The role of free radicals and membrane lipids in diabetes-induced congenital malformations. J Soc Gynecol Investig (1998) 0.97
Decoding the oxidative stress hypothesis in diabetic embryopathy through proapoptotic kinase signaling. Am J Obstet Gynecol (2014) 0.97
Abdominal wall endometriosis: 12 years of experience at a large academic institution. Am J Obstet Gynecol (2014) 0.96
Apoptosis and its pathway in early post-implantation embryos of diabetic rats. Diabetes Res Clin Pract (2005) 0.95
Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats. Antioxid Redox Signal (2004) 0.95
Pathogenesis of diabetes-induced congenital malformations. Ups J Med Sci (2000) 0.94
Advances in revealing the molecular targets downstream of oxidative stress-induced proapoptotic kinase signaling in diabetic embryopathy. Am J Obstet Gynecol (2015) 0.93
Mechanisms regulating toxicant disposition to the embryo during early pregnancy: an interspecies comparison. Birth Defects Res C Embryo Today (2004) 0.92
Synchronization of the factors critical for diabetic teratogenesis: an in vitro model. Am J Obstet Gynecol (1996) 0.92
Thioredoxin-1 suppresses lung injury and apoptosis induced by diesel exhaust particles (DEP) by scavenging reactive oxygen species and by inhibiting DEP-induced downregulation of Akt. Free Radic Biol Med (2005) 0.91
A consensus report of the Diabetes in Pregnancy Study Group of North America Conference, Little Rock, Arkansas, May 2002. J Matern Fetal Neonatal Med (2002) 0.91
Role of HIF-1α in maternal hyperglycemia-induced embryonic vasculopathy. Am J Obstet Gynecol (2011) 0.91
Apoptosis in normal rat embryo tissues during early organogenesis: the possible involvement of Bax and Bcl-2. Arch Histol Cytol (2002) 0.90
Yolk sac failure in embryopathy due to hyperglycemia: ultrastructural analysis of yolk sac differentiation associated with embryopathy in rat conceptuses under hyperglycemic conditions. Teratology (1986) 0.90
Placental vascular dysfunction in diabetic pregnancies: intimations of fetal cardiovascular disease? Microcirculation (2011) 0.89